Comment on “Joint effects and dynamic trajectories of metabolic insulin resistance and systemic inflammation in the risk of renal cell carcinoma: a UK Biobank cohort analysis” by Chen et al.
Authors:
- Amina NisarANAmina Nisar
- Ahmad AliAAAhmad Ali
- Payal DeviPDPayal Devi
- Muhammad Nihal TariqMTMuhammad Nihal Tariq
Open Access
- 6 August 2026
- journal article
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1)
Abstract
Highlights: METS-IR and SIRI associations with RCC remain observational. Diagnostic intensity and repeat-attendance selection may influence estimates. Trajectory findings do not establish reversibility of RCC risk.Keywords
This publication has 8 references indexed in Scilit:
- Imaging modality, incidental detection, and age–stage distribution in surgically treated clear cell renal cell carcinomaCancer Treatment and Research Communications, 2026
- Joint effects and dynamic trajectories of metabolic insulin resistance and systemic inflammation in the risk of renal cell carcinoma: a UK Biobank cohort analysisWorld Journal of Urology, 2026
- Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysisBMC Nephrology, 2025
- CT and MR utilization and morbidity metrics across Body Mass IndexPLOS ONE, 2024
- Reweighting UK Biobank corrects for pervasive selection bias due to volunteeringInternational Journal of Epidemiology, 2024
- Obesity and renal cell carcinoma: Biological mechanisms and perspectivesSeminars in Cancer Biology, 2023
- Quantifying bias in psychological and physical health in the UK Biobank imaging sub-sampleBrain Communications, 2022
- The Role of Metabolic Factors in Renal CancersInternational Journal of Molecular Sciences, 2020